Pharmagreen Financial Statements From 2010 to 2024
| PHBI Stock | USD 0 0.0001 5.26% |
Check Pharmagreen Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagreen Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmagreen financial statements analysis is a perfect complement when working with Pharmagreen Biotech Valuation or Volatility modules.
Pharmagreen |
Pharmagreen Biotech Company Return On Asset Analysis
Pharmagreen Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Pharmagreen Biotech Return On Asset | -2.3 |
Most of Pharmagreen Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmagreen Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Pharmagreen Biotech has a Return On Asset of -2.2974. This is 73.74% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is notably higher than that of the company.
Pharmagreen Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmagreen Biotech's current stock value. Our valuation model uses many indicators to compare Pharmagreen Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmagreen Biotech competition to find correlations between indicators driving Pharmagreen Biotech's intrinsic value. More Info.Pharmagreen Biotech is considered to be number one stock in return on asset category among its peers. It also is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Pharmagreen Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Pharmagreen Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Pharmagreen Biotech Financial Statements
Investors use fundamental indicators, such as Pharmagreen Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Pharmagreen Biotech's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada. Pharmagreen Biotech is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmagreen Pink Sheet
Pharmagreen Biotech financial ratios help investors to determine whether Pharmagreen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagreen with respect to the benefits of owning Pharmagreen Biotech security.